2007
DOI: 10.1007/s00259-007-0530-2
|View full text |Cite
|
Sign up to set email alerts
|

[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy

Abstract: Focally increased [(11)C]choline uptake in the prostatic bed reliably predicted local low volume occult relapsing prostate adenocarcinoma after radical prostatectomy and identified 71% of patients with a favourable biochemical response to local radiotherapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
86
0
11

Year Published

2009
2009
2018
2018

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 157 publications
(101 citation statements)
references
References 30 publications
4
86
0
11
Order By: Relevance
“…The sensitivities of 18 F-choline PET/CT increased with increasing trigger PSA levels (77.5%, 80.7%, 85.2%, and 92.8% at trigger PSA levels of .0.5, 1.0, 2.0, and 4.0 ng/mL, respectively) and were higher in patients who were receiving ongoing ADT (85%) than in patients who were not (59.5%) (P 5 0.001) (36). Other investigators have suggested that ADT may be withheld before examination to reduce the risk of false-negative scans and thereby to increase the rate of detection by 18 F-choline PET/CT (5,10,27,37).…”
Section: Bone Metastasesmentioning
confidence: 99%
See 1 more Smart Citation
“…The sensitivities of 18 F-choline PET/CT increased with increasing trigger PSA levels (77.5%, 80.7%, 85.2%, and 92.8% at trigger PSA levels of .0.5, 1.0, 2.0, and 4.0 ng/mL, respectively) and were higher in patients who were receiving ongoing ADT (85%) than in patients who were not (59.5%) (P 5 0.001) (36). Other investigators have suggested that ADT may be withheld before examination to reduce the risk of false-negative scans and thereby to increase the rate of detection by 18 F-choline PET/CT (5,10,27,37).…”
Section: Bone Metastasesmentioning
confidence: 99%
“…Various studies have investigated the diagnostic accuracy of 11 C-choline PET/CT for detecting PCa recurrence and have reported different values for sensitivity and specificity (5,(7)(8)(9)11,12,14). These variations could be attributed to the heterogeneity of patient populations in terms of inclusion criteria (i.e., PSA level, staging, and presence or absence of androgen deprivation therapy [ADT]).…”
Section: Influence Of Psa On Rate Of Detection By 11 C-choline Pet/ctmentioning
confidence: 99%
“…They summarized that PET-CT cannot be recommended as standard diagnostic tool for early relapse or suspicion of minimal persistent disease after surgery (level of evidence 3, see Table 2). Reske et al [32] in a single-centre retrospective study, analysed 49 patients into two groups. The group A included 36 patients with biochemical recurrence after RP and the group B (control group) 13 patients submitted to RP without biochemical relapse.…”
Section: Pet-ctmentioning
confidence: 99%
“…Many researchers have reported the usefulness of 11 C-choline PET/CT for restaging prostate cancer after RP, especially for detecting distant metastases most commonly to LNs and bones (2,3). However, only limited data on the utility of 11 Ccholine PET/CT regarding the detection of local recurrence after RP are available in the literature (4,5). Conversely, the combination of T2-weighted imaging and dynamic contrast-enhanced (DCE) MR imaging with endorectal coil has been shown to have an 84%-97% sensitivity and 74%-89% specificity for detecting local recurrence in the prostatectomy bed (6)(7)(8).…”
mentioning
confidence: 99%